Youcare Pharmaceutical Group Co. Ltd. A - Asset Resilience Ratio
Youcare Pharmaceutical Group Co. Ltd. A (688658) has an Asset Resilience Ratio of 12.41% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Youcare Pharmaceutical Group Co. Ltd. A (688658) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2024–2025)
This chart shows how Youcare Pharmaceutical Group Co. Ltd. A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Youcare Pharmaceutical Group Co. Ltd. A total assets.
Liquid Assets Composition Over Time
This chart breaks down Youcare Pharmaceutical Group Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 688658 current and long-term liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥626.62 Million | 12.41% |
| Total Liquid Assets | CN¥626.62 Million | 12.41% |
Asset Resilience Insights
- Moderate Liquidity: Youcare Pharmaceutical Group Co. Ltd. A has 12.41% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Youcare Pharmaceutical Group Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Youcare Pharmaceutical Group Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Abivax SA
PA:ABVX |
Biotechnology | 2.58% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Neuren Pharmaceuticals Ltd
AU:NEU |
Biotechnology | 90.43% |
|
Lifecome Biochemistry Co Ltd
SHE:002868 |
Biotechnology | 4.69% |
|
Pulike Biological Engineering
SHG:603566 |
Biotechnology | 17.82% |
|
Rocket Pharmaceuticals Inc
NASDAQ:RCKT |
Biotechnology | 14.00% |
|
NEWRON PHARMACEUT. EO-20
XETRA:NP5 |
Biotechnology | 41.67% |
|
Upstream Bio, Inc.
NASDAQ:UPB |
Biotechnology | 64.70% |
Annual Asset Resilience Ratio for Youcare Pharmaceutical Group Co. Ltd. A (2024–2025)
The table below shows the annual Asset Resilience Ratio data for Youcare Pharmaceutical Group Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 7.64% | CN¥397.81 Million ≈ $58.21 Million |
CN¥5.21 Billion ≈ $761.98 Million |
+4.85pp |
| 2024-12-31 | 2.79% | CN¥160.25 Million ≈ $23.45 Million |
CN¥5.74 Billion ≈ $839.67 Million |
-- |
About Youcare Pharmaceutical Group Co. Ltd. A
Youcare Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It offers drugs in various forms, such as injection, lyophilized powder injection, pills, tablets, capsules, ointments, creams, granules, etc. The company provides drugs in various categories, including covering cardio-cerebrovascular, antivirals, central… Read more